# Lifeloc Technologies, Inc > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Lifeloc Technologies, Inc). ## Overview Lifeloc Technologies designs and sells portable and fixed-station breath alcohol testing instruments, with a core franchise in evidential breathalyzers for law enforcement, workplace testing, and corrections. The company is also building a second growth leg in drug-detection technologies, including the SpinDetect/SpinDx product pipeline, while supporting customers with calibration systems, supplies, training, and services. ## Products & services • FC Series evidential breathalyzers • Workplace Series breath alcohol testers • Sentinel and passive screening stations • EASYCAL automatic calibration systems • Supplies, accessories, services, and training • SpinDetect/SpinDx drug-analysis development - **Breath alcohol testing instruments** (70%) — Portable hand-held and fixed-station breathalyzers used for evidential and screening applications. - **Calibration and support systems** (10%) — Automatic calibration tools and related hardware that keep testing programs compliant and operational. - **Supplies, accessories, and consumables** (8%) — Mouthpieces, accessories, and other recurring items used with breath-testing devices. - **Training and education** (7%) — Instructor-led and online training through Lifeloc University and related education assets. - **Drug-detection technology development** (5%) — Emerging product development for centrifugal drug-analysis and near/remote sensing solutions. - FC Series evidential breathalyzers - Workplace Series breath alcohol testers - Sentinel and passive screening stations - EASYCAL automatic calibration systems - Supplies, accessories, services, and training - SpinDetect/SpinDx drug-analysis development ## Customers Lifeloc sells to law enforcement agencies, corrections facilities, workplace safety programs, and OEM customers that need reliable alcohol testing equipment. It also serves distributors and direct end users globally, with demand tied to regulated testing, safety-sensitive workplaces, and compliance-driven screening programs. - **Law enforcement** (primary) — Buys evidential breathalyzers such as the FC Series for roadside and criminal enforcement use. - **Workplace testing** (primary) — Buys DOT-approved devices and calibration tools for federally regulated and safety-sensitive workplaces. - **Corrections** (secondary) — Buys portable and fixed testing systems for inmate and facility screening programs. - **OEM and component buyers** (secondary) — Buy components or subsystems, including ignition interlock-related parts and other testing hardware. - **Distributors and resellers** (secondary) — Buy inventory for local market distribution and to extend Lifeloc's geographic reach. - Law enforcement agencies buying evidential breathalyzers for roadside enforcement - Corrections customers needing reliable inmate testing and screening tools - Workplace safety programs in regulated industries and federally tested settings - OEM customers integrating components into their own testing solutions - Distributors that resell into local markets and support international reach ## Geography Lifeloc is headquartered in Wheat Ridge, Colorado and sells in the U.S. and internationally through direct sales and distributors. The company does not provide a country revenue table in the excerpts, but management explicitly says it is expanding domestic and international distribution and expects sales growth in the U.S. and worldwide. - Headquartered in Wheat Ridge, Colorado - Sells in the U.S. through direct sales and distributors - International sales are routed largely through distributors - Global reach matters because testing demand is compliance-driven - No country-level revenue split was disclosed in the excerpts ## Strategy Lifeloc is trying to broaden beyond alcohol breath testing into drug-detection technologies while continuing to support its installed base with training, calibration, and consumables. Management is also expanding direct sales and distributor coverage, which is intended to widen market access and improve repeat business from regulated customers. - **Commercialize new drug-detection products** (short-term) — A new product line could diversify revenue beyond breath alcohol testing and support a return to growth. - **Expand distribution and direct sales** (medium-term) — Broader market coverage should increase account wins and improve penetration in domestic and international markets. - **Strengthen customer retention through training and support** (medium-term) — Training, calibration, and service offerings make the installed base more sticky and support recurring revenue. - Expand from alcohol testing into drug-detection technologies - Grow direct sales and distributor coverage in the U.S. and abroad - Use training and Lifeloc University to deepen customer stickiness - Invest in SpinDetect/SpinDx to build a new product pipeline - Leverage installed base and recurring support revenue ## Risks The business is exposed to lumpy order patterns, especially for OEM and ignition-interlock-related components, and demand can swing with enforcement intensity and workplace testing activity. Lifeloc is also still investing in new products while operating losses continue, so execution risk around commercialization, distribution expansion, and cost control remains important. - **Lumpy customer ordering and repeat business risk** [high] — Many orders are placed on an intermittent purchase-order basis, so revenue may not recur at a steady rate. - **Commercialization risk for SpinDetect/SpinDx** [high] — The company is spending on development and demonstrations before the new platform is proven in the market. - **Operating loss risk** [high] — Management says losses have continued in 2025 and may continue until new products gain traction. - **Competitive and regulatory risk** [medium] — Products must remain approved, accurate, and competitively priced in regulated testing markets. - **Input cost inflation** [medium] — Raw materials, labor, and freight inflation can reduce gross margin if not passed through. - Intermittent purchase orders can make revenue uneven quarter to quarter - New product commercialization may take longer or cost more than expected - Operating losses may continue while SpinDetect is developed - Competition in breath testing can pressure pricing and product cycles - Supply chain, freight, and labor inflation can squeeze margins ## Accounting Key accounting judgments center on inventory valuation, bad debts, warranty, sales returns, deferred tax assets, and litigation or contingency reserves. The company also has meaningful estimates around depreciation, software/technology license lives, and amortization of acquired training assets, while the ongoing losses make recoverability and impairment assessments more important. - **Inventory reserves** — Gross margin and current assets - **Deferred tax assets** — Balance sheet and tax expense - **Warranty and sales returns** — Revenue, liabilities, and margins - **Amortization of acquired training assets** — Operating expenses and asset values - **Depreciation of property and equipment** — Operating income - Inventory reserves matter because demand can be intermittent and product cycles are long - Deferred tax asset valuation depends on whether future profits are sustained - Warranty and returns estimates affect gross margin and liability balances - Depreciation and amortization affect reported earnings and asset carrying values - Operating losses raise impairment and recoverability questions for assets and intangibles --- *Last updated: 2026-04-28T20:22:53.510692+00:00*